Strengthening Families & Communities LLC boosted its stake in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 1,923.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,654 shares of the pharmacy operator’s stock after purchasing an additional 30,090 shares during the quarter. Strengthening Families & Communities LLC’s holdings in CVS Health were worth $2,371,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also added to or reduced their stakes in the company. Hilltop National Bank bought a new position in shares of CVS Health during the 2nd quarter worth approximately $91,000. QRG Capital Management Inc. grew its holdings in CVS Health by 173.9% in the second quarter. QRG Capital Management Inc. now owns 92,896 shares of the pharmacy operator’s stock worth $6,408,000 after purchasing an additional 58,984 shares during the last quarter. Clarius Group LLC increased its position in shares of CVS Health by 13.1% during the second quarter. Clarius Group LLC now owns 3,611 shares of the pharmacy operator’s stock worth $249,000 after purchasing an additional 418 shares in the last quarter. Simplicity Wealth LLC purchased a new stake in shares of CVS Health during the 2nd quarter valued at $579,000. Finally, Grimes & Company Inc. lifted its holdings in shares of CVS Health by 5.8% during the 2nd quarter. Grimes & Company Inc. now owns 9,537 shares of the pharmacy operator’s stock valued at $658,000 after purchasing an additional 519 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.
CVS Health Trading Up 1.2%
Shares of CVS Health stock opened at $75.43 on Tuesday. The firm has a fifty day moving average price of $78.85 and a 200 day moving average price of $75.33. The stock has a market cap of $95.76 billion, a PE ratio of 198.51, a price-to-earnings-growth ratio of 0.69 and a beta of 0.50. CVS Health Corporation has a 1 year low of $53.36 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.
CVS Health Dividend Announcement
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on CVS. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 target price (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Sanford C. Bernstein restated a “market perform” rating and set a $91.00 price target on shares of CVS Health in a research note on Tuesday, January 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. UBS Group reissued an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.82.
Get Our Latest Stock Report on CVS
CVS Health Company Profile
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Stories
- Five stocks we like better than CVS Health
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
